<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261510/" ref="ordinalpos=1429&amp;ncbi_uid=6955598&amp;link_uid=PMC4261510" image-link="/pmc/articles/PMC4261510/figure/F0002/" class="imagepopup">Fig. 2.Hippo <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. Schematic diagram for the core components and signal transduction of Hippo <span class="highlight" style="background-color:">pathway</span>. (A) When Hippo <span class="highlight" style="background-color:">signaling</span> is Off (in low cell density): The kinases MST1/2 and LATS are inactive, which results in inhibition of phosphorylation of YAP and TAZ. The stabilized YAP/TAZ in nuclei interacts with TEAD and enhances the transcription of target genes related to anti-apoptosis and proliferation. (B) When Hippo <span class="highlight" style="background-color:">signaling</span> is On (in high cell density): Activation of KIBRA and NF2 via unknown upstream <span class="highlight" style="background-color:">signaling</span> leads to activation of MST1/2. Activated MST1/2 phosphorylate SAV1 which in turn phosphorylate LATS and MOB1. The activated LATS/MOB phosphorylates YAP/TAZ which results in cytoplasmic retention by 14-3-3 protein and proteasomal degradation of YAP/TAZ. As a result, TEAD interacts with VGL4 and suppresses the expression of target genes..  From: Cross-talk between Wnt/Î²-catenin and Hippo <span class="highlight" style="background-color:">signaling</span> pathways: a brief review. </a></div><br /><div class="p4l_captionBody"></div></div>